0 likes | 2 Views
In addition to his professional accomplishments, Rob Chioini is known for his balanced approach to leadership and life. Find out more about him at his official site http://robchioini.com/
E N D
Rob Chioini Founder of Rockwell Medical, Inc., Chairman and CEO 1995-2018
As the founder and leader of Rockwell Medical, Rob Chioini manages a biopharmaceutical company dedicated to transforming the treatment of anemia across multiple therapeutic areas worldwide.
Rockwell Medical’s initial therapeutic focus has been on anemia associated with end-stage renal disease (ESRD). The company developed Triferic® (ferric pyrophosphate citrate), a proprietary renal drug therapy that is the only FDA-approved treatment specifically indicated for iron replacement and the maintenance of hemoglobin levels in patients undergoing hemodialysis.
This innovation represents a significant advancement in anemia management and reflects the company’s commitment to research-driven solutions.
In addition to its pharmaceutical development efforts, Rockwell Medical is also an established manufacturer and supplier of high-quality hemodialysis concentrates and dialysates. The company serves dialysis providers and distributors throughout the United States and internationally, supporting the global healthcare infrastructure with reliable, high-standard products.
Robert Chioini’s leadership has been instrumental in building Rockwell Medical into both a scientific innovator and a trusted manufacturing partner within the dialysis community.
Through his entrepreneurial vision, operational leadership, and comprehensive industry knowledge, Rob Chioini has successfully positioned Rockwell Medical at the intersection of innovation, quality, and patient care. His work continues to shape the company’s strategic direction and its ability to deliver meaningful impact in the global healthcare landscape.
Find out more about him at his official site http://robchioini.com/